Manage Your Award

Photo Credit: UCLA Broad Stem Cell Research Center

Congratulations on Receiving a CIRM Award

The following information will help you comply with CIRM regulations and find information about our forms and policies.

If you have additional questions, contact your Grants Management Officer, or email the Grants Management Office at grantsmanagement@cirm.ca.gov.

Information for Awardees

To be in compliance with CIRM regulations, familiarize yourself with the below resources.

To understand the policy for your Award, review the below resources. Existing Awardees will be subject to the Award Management Policy (AMP) starting April 1, 2027. Until that date, CIRM will continue to enforce the current Clinical Stage Projects, and Discovery, Translation, and Education Projects Grants Administration Policies for active Awardees.

The Award Management Policy (AMP) is effective for all new Applicants and Awardees beginning October 1, 2026.

Applications opening after October 1, 2026, will incorporate AMP updates through CIRM’s standard Application cycle and Program Announcement or Request for Applications updates.

Applications that are currently active or opened prior to October 1, 2026, will transition to AMP requirements during Award launch at Pre-Funding Administrative Review (PFAR).

Resources for Awardees

CIRM supports a network of 11 shared resources laboratories (SRLs) for stem cell-based modeling. CIRM’s SRLs are core labs open to researchers and educators at any California research institution. Find labs, equipment, and expertise to support your stem cell-based modeling research.

CIRM requires Awardees to manage and preserve raw data, processed data, and metadata, and make applicable data and metadata available to the broader scientific community.

Detailed information about data sharing and management requirements at the Application and Award stages, plus general resources on repositories and data sharing, are described in CIRM Data Sharing and Management.

Preclinical (PDEV), Rare Disease Platform (RAPID), and Clinical (CLIN2) Awardees are required to demonstrate stage-appropriate progress on patient access planning activities. Complementary activities to support commercialization and market access are also recommended to advance these therapies to patients. The Patient Access Planning Requirements resource document details stage-appropriate patient access, market access, and commercialization activities. Stage-appropriate required patient access planning activities will be incorporated into Operational Milestones and Award reporting requirements as described in the Notice of Award.

Grants Management FAQs

To learn about current and past Awardees, visit the Grants Dashboard. Review the Grants Management FAQ for information and guidance from pre-Award planning to post-Award compliance.